Live
- Boeing lays off over 400 members of professional aerospace union
- Ready for debate on BRS 10 year rule and Congress one year's, TPCC Chief Mahesh Goud
- Director Arjun Jandhyala speaks about ‘Devaki Nandana Vasudeva’
- Amitabh Bachchan praises Bihar’s ‘LittiChokha’
- ‘Maha Sandram’ gets a grand launch
- Cong wants to break marginalised communities, BJP bats for everyone: PM Modi
- Sara Ali Khan enjoys camping under full moon
- Centre launches campaign for assessment year 2024-25 to help taxpayers
- Dutch cabinet holds out after crisis talks
- Rashmikasparks buzz on Grazia cover page
Mehta to steer MedGenome India
Highlights
MedGenome Labs Private Limited, which is into clinical genomics in India, has appointed Girish Mehta as its Chief Executive Officer for India.
MedGenome Labs Private Limited, which is into clinical genomics in India, has appointed Girish Mehta as its Chief Executive Officer for India.
Mehta has previously served as CEO of Oncquest Laboratories Private Limited (Oncquest) and Piramal Diagnostic Services Private Limited. An alumnus of IIT Mumbai and IIM Kolkata, Girish’s leadership experience spans across all key sectors of healthcare including pharmaceuticals, diagnostic services, diagnostic instrumentation and consumables, medical consumables and hospitals.
“I am pleased to welcome Girish Mehta as CEO of MedGenome India. He has extensive experience in growing specialized businesses in healthcare and leading a fast-paced organization” said Sam Santhosh, Chairman, MedGenome.
MedGenome, a first mover in genomics-based diagnostics and research from India, has two state-of-the-art next generation sequencing labs in the country and is the highest throughput sequencing lab in South East Asia. It offers over 100 genetic tests for neurological disorders, cancer, cardiac disorders, eye-disorder, among others and is the only genetic facility in the country that has been validated to run a non-invasive prenatal test (NIPT) to screen for chromosomal disorders in the baby’s DNA, through its technology collaboration with Natera on PanoramaTM NIPT. It offers its genomics solutions to global pharmaceutical and biotechnology companies to support their exploratory research and drug development programs.
Next Story
ADVERTISEMENT
